NCT05962684 (ERAS) is a clinical trial of ERAS in ERAS, sponsored by University of Thessaly.

Who is sponsoring NCT05962684?

NCT05962684 is sponsored by University of Thessaly.

What drugs are being tested in NCT05962684?

Interventions in NCT05962684: ERAS.

What condition does NCT05962684 study?

NCT05962684 studies ERAS, Craniotomy.

Is NCT05962684 still recruiting?

NCT05962684 is currently status unknown. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05962684: ERAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Greek-designed ERAS Protocol in Elective Craniotomy

Status unknown Last updated 27 July 2023

What this trial tests

trial testing ERAS in ERAS in 30 participants. Status unknown.

Timeline

31 May 2023

Primary endpoint
31 May 2024

30 July 2024

Quick facts

Lead sponsor	University of Thessaly
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	31 May 2023
Primary completion	31 May 2024
Estimated completion	30 July 2024
Sites	1 location across Greece

Drugs / interventions tested

ERAS

Conditions studied

ERAS — all drugs for ERAS →
Craniotomy — all drugs for Craniotomy →

Sponsor

University of Thessaly

Who can join

18 and older, any sex, with ERAS or Craniotomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The implementation of ERAS protocol in elective cranial neurosurgical cases in a tertiary hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ERAS

Trials testing the same drug.

NCT07225205 — Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy · NA · recruiting
NCT07081802 — Effect of Acupuncture and Herbal Medicine on Bowel Recovery After Abdominal Surgery · NA · not yet recruiting
NCT07017361 — ERAS Program Implementation for MIPD · NA · not yet recruiting
NCT05914090 — The Application of Enhanced Recovery After Surgery (ERAS) for Cardiovascular Surgery in Adult · NA · unknown
NCT05914103 — The Application of Enhanced Recovery After Surgery (ERAS) for Cardiovascular Surgery in the Correction of Complex Congen · NA · unknown

Other recruiting trials for ERAS

Currently open trials in the same condition.

NCT07276126 — The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlle · NA · recruiting
NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
NCT07116564 — Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries · Phase 4 · recruiting
NCT07087366 — Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital · NA · recruiting
NCT06786819 — Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery B · NA · recruiting

Other University of Thessaly trials

Trials by the same sponsor.

NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05962684 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing